Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial

Clinical trial NCT02440958 · COMPLETED

Trial details

NCT number: NCT02440958
Sponsor: Yonsei University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma

Start date: 2015-08-28
Primary completion: 2017-03-02
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.